Alzheimer's disease-specific extracellular vesicles: from pathology to novel biomarker discovery
Alzheimer's disease-specific extracellular vesicles: from pathology to novel biomarker discovery
批准号:
10739392
负责人:
Vasiliki Machairaki
金额:
$239.96万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31
关键词:
AffectAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease careAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloid beta-ProteinAstrocytesBackBindingBiologicalBiological MarkersBiologyBloodBrainBrain DiseasesCause of DeathCell DensityCell membraneCellsCentral Nervous SystemClinicalCognitionCognitiveCommunicationComparative StudyDementiaDetectionDiagnosticDiseaseDisease ProgressionEndosomesEnvironmentFamilyHumanImpaired cognitionImpairmentIndividualInduced pluripotent stem cell derived neuronsLipoproteinsMembraneMemory LossMicrogliaMolecularMolecular ProfilingMonitorNerve DegenerationNeurodegenerative DisordersNeuronsOrganParentsPathogenesisPathogenicityPathologyPatientsPeripheralPhenotypePlasmaPluripotent Stem CellsPrevalenceProteinsProteomeProteomicsProtocols documentationPublic HealthRNAReagentResearchRoleSamplingSensitivity and SpecificitySourceSurfaceTestingTissuesUniversitiesbiomarker discoverybiomarker identificationbrain cellbrain healthbrain tissuecell typecomparativedruggable targetearly detection biomarkersexosomeextracellular vesiclesimprovedinduced pluripotent stem cellliquid biopsymind controlnervous system disorderneuroprotectionneuropsychiatryneurotransmissionnovelnovel diagnosticsnovel markerparticlepotential biomarkerprecision medicineprognosticprotein aggregationstem cell modelsubmicrontau Proteinstherapeutic biomarkertoolvesicular release
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Alzheimer’s disease (AD) is one of the most devastating neurological diseases characterized by
progressive cognitive impairments, including memory loss. The mechanisms of disease
progression are not yet fully elucidated, and to date there are no reliable biomarkers for early
detection of pathogenic components. Improved capabilities to assess central nervous system
brain health with peripheral biofluid samples (Liquid Biopsy) will expand clinical options at all
stages of disease.
Extracellular vesicles (EVs) of brain origin (bdEVs) cross biological barriers and can be traced
back to specific parent cell types suggesting novel diagnostic, prognostic, and monitoring tools,
revolutionizing identification and care of AD as well as understanding pathogenesis. bdEVs
carry cargos involved in neurotransmission or neuroprotection and facilitate communication
between brain cells also making them “targetable agents” of pathology.
To lay the groundwork for more efficient peripheral bdEV studies, we have compared the protein
content of brain homogenates with purified EV fractions of control and late-stage AD brains.
Proteome differences were most pronounced in EVs, while certain cells release more EVs or
EVs with higher density of cell-specific surface markers. Based on these novel findings, we
propose to use human induced pluripotent stem cell (hiPSC) models of neurons, astrocytes and
microglia to test the specificity and sensitivity of the top CNS surface markers we identified in
our preliminary studies as enriched on bdEVs from different cell types and as more abundant in
AD patients versus controls (Aim 1). To investigate aging- and neurodegeneration-related
proteins and RNAs that were differentially regulated in AD bdEVs, we will study three different
sources of EVs, including iPSC-derived progeny (Aim 1), brain tissue (Aim 2), and plasma (Aim
3). We will use the same sources to discover new molecular signatures for disease detection
and monitoring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A personalized medicine approach to the study of monoamine brain systems that underlie the emergence of neuropsychiatric symptoms in person with Alzheimer's disease
-
批准号:9896487
-
项目类别:
-
资助金额:$45.03万
-
财政年份:2020
-
负责人:Vasiliki Machairaki
-
依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
-
批准号:9913760
-
项目类别:
-
资助金额:$2.06万
-
财政年份:2019
-
负责人:Vasiliki Machairaki
-
依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
-
批准号:10019695
-
项目类别:
-
资助金额:$75.84万
-
财政年份:2018
-
负责人:Vasiliki Machairaki
-
依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
-
批准号:9789936
-
项目类别:
-
资助金额:$24.57万
-
财政年份:2018
-
负责人:Vasiliki Machairaki
-
依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
-
批准号:10261457
-
项目类别:
-
资助金额:$72.43万
-
财政年份:2018
-
负责人:Vasiliki Machairaki
-
依托单位:
Novel Approaches to Capture, Sorting, and Characterization of CNS-Origin Extracellular Vesicles
-
批准号:10471286
-
项目类别:
-
资助金额:$68.83万
-
财政年份:2018
-
负责人:Vasiliki Machairaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: